Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris

Archives of Virology

Volumn 150, Issue 5, 2005, Pages 967-979

  Balamurugan, V ^a   Renji, R ^a   Venkatesh, G ^a   Reddy, G R ^a   Nair, S P ^a   Ganesh, K ^a   Suryanarayana, V V S ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL; ARTICLE; BLOOD; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; GUINEA PIG; IMMUNOLOGY; MALE; METABOLISM; PATHOGENICITY; PICHIA; SERODIAGNOSIS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; MALE; NEUTRALIZATION TESTS; PICHIA; POLYPROTEINS; VACCINATION; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

CAVIA; CAVIA PORCELLUS; FOOT-AND-MOUTH DISEASE VIRUS; PICHIA PASTORIS; SUS SCROFA;

EID: 17644377944     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0460-2     Document Type: Article

References (46)

1. Abrams CC, King AMQ, Belsham GJ (1995) Assembly of foot-and-mouth disease virus empty capsids synthesised by a vaccinia virus expression system. J Gen Virol 76: 3089-3098
2. Abu Elzein EME, Crowther JR (1978) Enzyme-labelled immunosorbent assay techniques in foot and mouth disease virus research. J Hyg Camb 80: 391-399
3. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F (1989) Three dimensional structure of foot and mouth disease virus at 2.9° resolution. Nature 337: 709-716
4. Anderson EC, Masters RC, Mowat GN (1971) Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccine. Res Vet Sci 12: 342-350
5. Bachrach HL, Morre DM, Mckercher PD, Polatnick J (1975) J Immunol 115: 1636-1641 (cited from Suryanarayana et al, 1992 [44])
6. Bahnemann H, Mesquita J, Astudillo V, Dora F (1987) Production and application of an oil adjuvant vaccine against foot-and-mouth disease in cattle. In: Spier RE, Griffith JB (ed) Modern approaches to animal cell technology, vol 1. Butterworth and Co, Guildford, pp 628-640
7. Balamurugan V, Renji R, Saha SN, Reddy GR, Gopalakrishna S, Suryanarayana VVS (2003) Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris. Virus Res 92: 141-149
8. Barnett PV, Pullen L, Williams L, Doel TR (1996) International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine 14: 1187-1198
9. Barteling SJ, Vreeswijk L (1991) Development of foot and mouth disease vaccines. Vaccine 9: 75-88
10. Bayry J, Prabhudas K, Gopalakrishna S, Patil PK, Ramakrishna C, Mishra LD, Suryanarayana VVS (1999a) Protective immune response to 16kDa immunoreactive recombinant protein encoding the C-terminal VP1 portion of foot and mouth disease virus type Asia 1. Microbiol Immunol 43: 768-771
11. Bayry J, Indi SS, Prabhudas K, Suryanarayana VVS (1999b) Preparation of ISCOMs with urea solubilized recombinant FMDV protein. Vaccine 17: 2333-2334
12. Black L, Francis MJ, Rweyemamu MM, Umehara O, Boge A (1984) The relationship between serum antibody titres and protection from foot-and-mouth disease in pigs after oil emulsion vaccination. J Bio Stand 12: 379-389
13. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
14. Cereghino JL, Cregg JM (2000) Heterologous protein expression in methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24: 45-66
15. Cregg JM, Higgins DR (1995) Production of Foreign protein in yeast Pichia pastoris. Can J Botany (Suppl) 73: 5981-5987
16. Doel TR, Chong WKT (1982) Comparative immunology of 146s, 75s and 12s particles of foot-and-mouth disease. Arch Virol 73: 185-191
17. Domingo E, Mateu MG, Martine MA, Dopazo J, Moya A, Sobrino F (1990) Genetic variability and antigenic diversity of foot and mouth disease virus. In: Kurstak E, Marusyk RG, Murphy FA, Van Ragenmortel MHV (ed) Applied virology research, virus variability, epidemiology and control, vol 2. Plenum Press, New York, pp 233-266
18. Forss S, Strebel K, Beck E, Schaller H (1984) Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12: 6587-6591
19. Gomes I, De Mello PA, Fernandez AA, Costa KF (1979) Foot-and-mouth disease oil adjuvanted vaccines for pigs: immune response of vaccines emulsified by ultrasonic or mechanical equipment. Bltn Centro Panamericano Fibre Aftosa 35-36: 27-33
20. Iyer AV, Ghosh S, Singh SN, Deshmukh RA (2001) Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production. Vaccine 19: 1097-1105
21. Johnston BA, Eisen H, Fry D (1991) An evaluation of several adjuvant emultion regimens for the production of polyclonal antisera in rabbits. Lab Anim Sci 4: 15-21
22. King AM, Underwood BO, McCahon D, Newman JW, Brown F (1981) Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in UK. Nature 293: 479-480
23. Kleid DG, Yansura D, Small B, Dowbenko D, Moore DM, Grubman MJ (1981) Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214: 1125-1129
24. Laemmli UK (1970) Cleavage of structural protein during the analysis of head of bacteriophage T4. Nature 227: 680-685
25. Lewis SA, Morgan DO, Grubman MJ (1991) Expression, processing and assembly of foot-and-mouth-disease virus capsid structures in heterologous system: induction of a neutralizing antibody response in Guinea pigs. J Virol 65: 6572-6580
26. Lucam F, Fedida M, Dannachie G (1964) Mesure de I' immunite anti-aphteuse post-vaccinate du boeuf, par e preuve sar le cobage. Rev Med Vet 115: 225-245
27. Mateu MG, Hernandez J, Martinez MA, Feigelstock D, Lea S, Perez JJ, Giralt E, Stuart D, Palma EL, Domingo E (1994) Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 68: 1407-1417
28. McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm U (1992) Protective immune response against foot-and-mouth disease. J Virol 66: 1835-1840
29. McCullough KC, Schaffner R, Fraefel W, Ackermann M, Bruckner L, Muller HK, Kihm U (1991) Immunoassay application in FMD serodiagnosis and vaccine control: an immunological approach. In: Session of the Research Group of the Standing Technical Committee of the European Commission for the control of FMD, Lindholm, Denmark. Food and Agricultural Organization, Rome, pp 61-66
30. Montanide and Montanide ISA adjuvants for Vaccines (1994) Seppic Technical Bulletin, SEPPIC, Paris
31. Nair SP, Sen AK (1992) Comparative study on the immune response of sheep to foot-and-mouth disease vaccine type Asia-1 prepared with different inactivants and adjuvants. Comp Immun Microbiol Infect Dis 15: 117-124
32. Pay TWF, Hingley PJ (1987) Correlation of 140S antigen dose the serum neutralizing antibody response and the level of protection induced in cattle by foot and mouth disease vaccines. Vaccine 5: 60-64
33. Reddy GR, Tratschin JD, Natarajan C, Suryanarayana VVS (1999) Capsid protein encoding (P1) sequence of foot and mouth disease virus type Adia 1 Ind 63/72. Virus Genes 18: 161-168
34. Reed LJ, Muench H (1938) A simple method of estimating 50 percent end points. Am J Hyg 27: 493-497
35. Romanos MA, Clare JJ, Beesley KM, Rayment FB, Ballantine ST, Makoff AJ, Dougan G, Fairweather NF, Charles IG (1991) Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties. Vaccine 9: 901-906
36. Rombaut B, Jore JPM (1997) Immunogenic non-infectious polio subviral particles synthesized in Saccaromyces cerveseae. J Gen Virol 78: 1829-1832
37. Roosien J, Belsham GJ, Ryan MD, King AM, Vlak JM (1990) Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol 71: 1703-1711
38. Rweyemamu M, Booth JC, Head M, Pay TWF (1978) Micro neutralization test for the serological typing and sub typing of the foot-and-mouth disease virus strains. J Hyg Camb 81: 107-123
39. Rweyemamu MM, Terry G, Pay TWF (1979) Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol 59: 69-79
40. Saiz JC, Cairo J, Medina M, Zuidema D, Abrans C, Belsham G, Domingo E, Vlak JM (1994) Unprocessed FMDV capsid precursor displays discontinous epitopes involved in viral neutralization. J Virol 68: 4557-4564
41. Skern T, Hampolz B, Guarne A, Fita I, Bergmann E, Petersen J, James MNG (2002) Structure and function of Picornavirus proteinases. In: Semler BL, Wimmer E (ed), Molecular biology of picornaviruses. ASM Press, Washington, pp 199-212
42. Surgrue RJ, Fu J, Howe J, Chan YC (1997) Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles. J Gen Virol 78: 1861-1866
43. Suryanarayana VVS, Madanmohan B, Bhist P, Natarajan C, Tratschin JD (1999) Serotyping of foot-and-mouth disease virus by antigen capture Reverse Transcriptase polymerase chain reaction. J Virol Methods 80: 45-52
44. Suryanarayana VVS, Venkataraman R, Padayatty JD (1992) Characterization and immune response of a protein produced by a cDNA clone of foot-and-mouth disease virus type Asia-1 63/72. Biochem Int 26: 1003-1016
45. Vozza LA, Wittwer L, Higgins DR, Purcell TJ, Bergseid M, Collins-Racie LA, LaVallie ER, Hoffler JP (1996) Production of a recombinant bovine enterokinase catalystic subunit in the methylotropic yeast Pichia pastries. Biotechnology 14: 77-81
46. Wigdorovitz A, Zamorano P, Borca MV, Sadir AM (1998) Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: aviridine and a water soluble fraction of mycobacterium sp. Vaccine 16: 1627-1632